Both in Pharmaceuticals
BeOne Medicines vs Structure Therapeutics
Over the past year ONC returned +23.6% and GPCR returned −40.0%; their daily moves had a correlation of 0.20.
ONC +23.6% GPCR −40.0%Growth of $1, one year, split-adjusted
| Metric | ONC | GPCR |
|---|---|---|
| Price | $406.96 | $20.35 |
| Market cap | $46.49B | $1.45B |
| Today | +5.09% | +6.66% |
| 1 month | +16.2% | −20.7% |
| 6 months | +30.4% | −48.0% |
| Year to date | +34.0% | −70.7% |
| 1 year | +26.6% | −36.8% |
| Revenue growth (YoY) | +29.6% | — |
| Gross margin | 89.8% | — |
| Net margin | 13.9% | — |
| P/E (TTM) | 70.9× | — |
| Price / sales | 7.6× | — |
| Net cash | $4.02B | $1.34B |
| Dividend yield | — | — |
| Volatility (60d) | 33.3% | 59.3% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).